Jari K. Gool
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jari K. Gool has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
Gert Jan Lammers
Sleep‐Wake Centre, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede the Netherlands
7 shared publicationsRolf Fronczek
Sleep‐Wake Centre, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede the Netherlands
7 shared publications- Rolf Fronczek
Stichting Epilepsie Instellingen Nederlands (SEIN) Sleep‐wake Center Heemstede the Netherlands
6 shared publications - Gert Jan Lammers
Stichting Epilepsie Instellingen Nederlands (SEIN) Sleep‐wake Center Heemstede the Netherlands
5 shared publications - Ysbrand D. van der Werf
Department of Anatomy & Neurosciences, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, North Holland, The Netherlands
5 shared publications Aleksandra Wierzbicka
Department of Clinical Neurophysiology Institute of Psychiatry and Neurology Warsaw Poland
3 shared publications
Latest Publications
- 11 November 2026
- Published by Wiley in Journal of Sleep Research
2010 and 2013 Incidence Peaks in Narcolepsy and Idiopathic Hypersomnia Linked to Type A H1N1 and Type B Victoria Influenza Strains
Increased narcolepsy type‐1 (NT1) incidence rates were reported globally in 2010, linked to the H1N1 2009–2010 influenza pandemic and Pandemrix vaccination. A child‐specific NT1 peak was observed in Europe in 2013, further raising questions about the relationship between NT1 and influenza infections. This study analysed annual European incidence patterns of central disorders of hypersomnolence (CDH) in relation to influenza severity. All NT1 ( N = 981) and a combined group of narcolepsy type‐2 (NT2) and idiopathic hypersomnia (IH) ( N = 545) cases from eight European centers were studied from 1995 to 2019. Linear mixed models and Spearman correlations were applied to investigate the relationships between CDH incidence and the severity of preceding influenza seasons, including H1N1, H3N2, and for the Netherlands, influenza Type B Victoria and Yamagata. Peaks in NT1 incidence were present in 2010 and 2013, while a 2010 child‐specific peak was identified in NT2 and IH. Both groups showed a significantly positive correlation with H1N1 influenza severity and a negative correlation with H3N2. NT1 was also significantly associated with influenza Type B Victoria in the Netherlands, particularly in children. These findings suggest that, beyond H1N1, influenza Type B Victoria may be a novel trigger for NT1. Similar to NT1, the 2010 children peak in NT2 and IH may indicate possible immune‐related pathophysiologies linked to the 2009–2010 H1N1 pandemic. Further immunological studies are warranted to unravel the complexities of these relationships and their implications for CDH.
- 11 November 2026
- Published by Wiley in Journal of Sleep Research
2010 and 2013 Incidence Peaks in Narcolepsy and Idiopathic Hypersomnia Linked to Type A H1N1 and Type B Victoria Influenza Strains
Increased narcolepsy type‐1 (NT1) incidence rates were reported globally in 2010, linked to the H1N1 2009–2010 influenza pandemic and Pandemrix vaccination. A child‐specific NT1 peak was observed in Europe in 2013, further raising questions about the relationship between NT1 and influenza infections. This study analysed annual European incidence patterns of central disorders of hypersomnolence (CDH) in relation to influenza severity. All NT1 ( N = 981) and a combined group of narcolepsy type‐2 (NT2) and idiopathic hypersomnia (IH) ( N = 545) cases from eight European centers were studied from 1995 to 2019. Linear mixed models and Spearman correlations were applied to investigate the relationships between CDH incidence and the severity of preceding influenza seasons, including H1N1, H3N2, and for the Netherlands, influenza Type B Victoria and Yamagata. Peaks in NT1 incidence were present in 2010 and 2013, while a 2010 child‐specific peak was identified in NT2 and IH. Both groups showed a significantly positive correlation with H1N1 influenza severity and a negative correlation with H3N2. NT1 was also significantly associated with influenza Type B Victoria in the Netherlands, particularly in children. These findings suggest that, beyond H1N1, influenza Type B Victoria may be a novel trigger for NT1. Similar to NT1, the 2010 children peak in NT2 and IH may indicate possible immune‐related pathophysiologies linked to the 2009–2010 H1N1 pandemic. Further immunological studies are warranted to unravel the complexities of these relationships and their implications for CDH.
- Open Access
- 18 June 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (10)
How (long) did you sleep last night?
- 18 June 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (10)
Open AccessHow (long) did you sleep last night?
- Open Access
- 18 February 2025
- Published by Wiley in Journal of Sleep Research
- Vol. 34 (6) , e14479
MRI ‐based surrogates of brain clearance in narcolepsy type 1
Summary: Brain clearance involves the drainage of waste molecules from the brain, a process that is suggested to be amplified during sleep. Recently proposed MRI‐based methods attempt to approximate human brain clearance with surrogate measures. The current study aimed to explore whether two brain clearance surrogates are altered in narcolepsy. We processed diffusion‐weighted and functional resting‐state images to extract two surrogates: Diffusion Tensor Imaging Along the Perivascular Space (DTI‐ALPS index), and dBOLD‐CSF coupling. Both measures were analysed in 12 drug‐free, awake people with narcolepsy type 1 and 11 age‐ and sex‐matched controls, as well as in relation to clinical features. We also assessed the correlation between the DTI‐ALPS index and dBOLD‐CSF coupling. The DTI‐ALPS index and dBOLD‐CSF coupling amplitude did not show significant differences between narcolepsy and controls, nor significant relations with the severity of excessive daytime sleepiness. We found a significant correlation between dBOLD‐CSF coupling and sleep efficiency, as well as a significant correlation between the DTI‐ALPS index and dBOLD‐CSF coupling. The hypothesis of altered brain clearance in narcolepsy type 1 is not supported by evidence from the current study. The two surrogates correlated with each other, suggesting that both offer different perspectives from the same underlying physiology. Yet, the suitability of the surrogates as brain clearance markers remains debatable. Whereas DTI is not exclusively sensitive to perivascular fluid, dBOLD‐CSF coupling is reflecting large‐scale CSF motion. Future work should explore other surrogate markers, preferably during sleep, to better understand the possible role of altered brain clearance in narcolepsy type 1 symptomatology.
- 18 February 2025
- Published by Wiley in Journal of Sleep Research
- Vol. 34 (6) , e14479
Open AccessMRI ‐based surrogates of brain clearance in narcolepsy type 1
Summary: Brain clearance involves the drainage of waste molecules from the brain, a process that is suggested to be amplified during sleep. Recently proposed MRI‐based methods attempt to approximate human brain clearance with surrogate measures. The current study aimed to explore whether two brain clearance surrogates are altered in narcolepsy. We processed diffusion‐weighted and functional resting‐state images to extract two surrogates: Diffusion Tensor Imaging Along the Perivascular Space (DTI‐ALPS index), and dBOLD‐CSF coupling. Both measures were analysed in 12 drug‐free, awake people with narcolepsy type 1 and 11 age‐ and sex‐matched controls, as well as in relation to clinical features. We also assessed the correlation between the DTI‐ALPS index and dBOLD‐CSF coupling. The DTI‐ALPS index and dBOLD‐CSF coupling amplitude did not show significant differences between narcolepsy and controls, nor significant relations with the severity of excessive daytime sleepiness. We found a significant correlation between dBOLD‐CSF coupling and sleep efficiency, as well as a significant correlation between the DTI‐ALPS index and dBOLD‐CSF coupling. The hypothesis of altered brain clearance in narcolepsy type 1 is not supported by evidence from the current study. The two surrogates correlated with each other, suggesting that both offer different perspectives from the same underlying physiology. Yet, the suitability of the surrogates as brain clearance markers remains debatable. Whereas DTI is not exclusively sensitive to perivascular fluid, dBOLD‐CSF coupling is reflecting large‐scale CSF motion. Future work should explore other surrogate markers, preferably during sleep, to better understand the possible role of altered brain clearance in narcolepsy type 1 symptomatology.
- 15 November 2024
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (4)
Measuring energy expenditure in narcolepsy using doubly labeled water and respiration chamber calorimetry
Study Objectives: Hypocretin deficiency causes type 1 narcolepsy, a condition characterized by excessive daytime sleepiness, cataplexy, and fragmented nocturnal sleep. Two-thirds of people with narcolepsy are also overweight, of which half are obese. The pathophysiology behind weight gain in people with narcolepsy remains unknown. We assessed a possible decrease in energy expenditure as a cause for overweight in narcolepsy using respiration chamber calorimetry and doubly labeled water. Methods: Ten males with type I narcolepsy and nine matched (for age, sex, and BMI) healthy controls were enrolled. Participants stayed in a respiration chamber for 24 hours. They subsequently received doubly labeled water and wore an accelerometer for 2 weeks to assess energy expenditure and physical activity under daily living conditions. Total daily energy expenditure, resting energy expenditure (REE), overnight metabolic rate, physical activity level, and activity-induced energy expenditure were measured. Results: No significant differences were found in REE, mean 24-hour respiration chamber energy expenditure, overnight metabolic rate, and activity-induced energy expenditure when comparing people with narcolepsy type 1 to controls. Physical activity was also comparable between groups. Conclusions: Energy expenditure in narcolepsy type 1 is similar to matched controls, suggesting comparable metabolism and physical activity rates. It remains possible that metabolic changes are most pronounced around disease onset. In addition, patients had to discontinue their medication which may have influenced the results. Still, our findings suggest that other factors may also play a role in weight gain in narcolepsy, such as differences in dietary behavior.
- 15 November 2024
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (4)
Measuring energy expenditure in narcolepsy using doubly labeled water and respiration chamber calorimetry
Study Objectives: Hypocretin deficiency causes type 1 narcolepsy, a condition characterized by excessive daytime sleepiness, cataplexy, and fragmented nocturnal sleep. Two-thirds of people with narcolepsy are also overweight, of which half are obese. The pathophysiology behind weight gain in people with narcolepsy remains unknown. We assessed a possible decrease in energy expenditure as a cause for overweight in narcolepsy using respiration chamber calorimetry and doubly labeled water. Methods: Ten males with type I narcolepsy and nine matched (for age, sex, and BMI) healthy controls were enrolled. Participants stayed in a respiration chamber for 24 hours. They subsequently received doubly labeled water and wore an accelerometer for 2 weeks to assess energy expenditure and physical activity under daily living conditions. Total daily energy expenditure, resting energy expenditure (REE), overnight metabolic rate, physical activity level, and activity-induced energy expenditure were measured. Results: No significant differences were found in REE, mean 24-hour respiration chamber energy expenditure, overnight metabolic rate, and activity-induced energy expenditure when comparing people with narcolepsy type 1 to controls. Physical activity was also comparable between groups. Conclusions: Energy expenditure in narcolepsy type 1 is similar to matched controls, suggesting comparable metabolism and physical activity rates. It remains possible that metabolic changes are most pronounced around disease onset. In addition, patients had to discontinue their medication which may have influenced the results. Still, our findings suggest that other factors may also play a role in weight gain in narcolepsy, such as differences in dietary behavior.
- Open Access
MRI-based surrogates of brain clearance in narcolepsy type 1
Brain clearance involves the drainage of waste molecules from the brain, a process that is suggested to be amplified during sleep. Recently proposed MRI-based methods attempt to approximate human brain clearance with surrogate measures. The current study aimed to explore whether two brain clearance surrogates are altered in narcolepsy. We processed diffusion-weighted and functional resting-state images to extract two surrogates: Diffusion Tensor Imaging Along the Perivascular Space (DTI-ALPS index), and dBOLD-CSF coupling. Both measures were analysed in 12 drug-free, awake people with narcolepsy type 1 and 11 age- and sex-matched controls, as well as in relation to clinical features. We also assessed the correlation between the DTI-ALPS index and dBOLD-CSF coupling. The DTI-ALPS index and dBOLD-CSF coupling amplitude identified were similar to previous research and did not show significant differences between narcolepsy and controls, nor significant relations with severity of excessive daytime sleepiness. We found a significant correlation between the DTI-ALPS index and dBOLD-CSF coupling amplitude. The hypothesis of altered brain clearance in narcolepsy type 1 is not supported by evidence from the current study. The two surrogates correlated with each other, suggesting that both offer different perspectives from the same underlying physiology. Yet, the suitability of the surrogates as brain clearance markers remains debatable. Whereas DTI is not exclusively sensitive to perivascular fluid, dBOLD-CSF coupling is reflecting large-scale CSF motion. Future work should explore other surrogate markers, preferably during sleep, to better understand the possible role of altered brain clearance in narcolepsy type 1 symptomatology.
Open AccessMRI-based surrogates of brain clearance in narcolepsy type 1
Brain clearance involves the drainage of waste molecules from the brain, a process that is suggested to be amplified during sleep. Recently proposed MRI-based methods attempt to approximate human brain clearance with surrogate measures. The current study aimed to explore whether two brain clearance surrogates are altered in narcolepsy. We processed diffusion-weighted and functional resting-state images to extract two surrogates: Diffusion Tensor Imaging Along the Perivascular Space (DTI-ALPS index), and dBOLD-CSF coupling. Both measures were analysed in 12 drug-free, awake people with narcolepsy type 1 and 11 age- and sex-matched controls, as well as in relation to clinical features. We also assessed the correlation between the DTI-ALPS index and dBOLD-CSF coupling. The DTI-ALPS index and dBOLD-CSF coupling amplitude identified were similar to previous research and did not show significant differences between narcolepsy and controls, nor significant relations with severity of excessive daytime sleepiness. We found a significant correlation between the DTI-ALPS index and dBOLD-CSF coupling amplitude. The hypothesis of altered brain clearance in narcolepsy type 1 is not supported by evidence from the current study. The two surrogates correlated with each other, suggesting that both offer different perspectives from the same underlying physiology. Yet, the suitability of the surrogates as brain clearance markers remains debatable. Whereas DTI is not exclusively sensitive to perivascular fluid, dBOLD-CSF coupling is reflecting large-scale CSF motion. Future work should explore other surrogate markers, preferably during sleep, to better understand the possible role of altered brain clearance in narcolepsy type 1 symptomatology.
- Open Access
- 21 October 2024
- Published by Wiley in Journal of Sleep Research
- Vol. 34 (3) , e14365
Daytime sleepiness and BMI exhibit gender and age differences in patients with central disorders of hypersomnolence
Summary: The aim of the present study was to examine gender and age‐specific effects on subjective daytime sleepiness (as measured by the Epworth Sleepiness Scale), body weight and eating behaviour in patients with central disorders of hypersomnolence. Based on the European Narcolepsy Network database, we compared 1035 patients with narcolepsy type I and 505 patients with other central disorders of hypersomnolence (“narcoleptic borderland”), including narcolepsy type II (N = 308) and idiopathic hypersomnia (N = 174), using logistic regression and general linear models. In the entire study population, the Epworth Sleepiness Scale was higher in women (N = 735, mean age = 30 years, mean Epworth Sleepiness Scale = 16.6 ± SD 3.9) than in men (N = 805, mean age = 32 years, mean Epworth Sleepiness Scale = 15.8 ± SD 4.4). In women with narcolepsy type I (N = 475), both Epworth Sleepiness Scale and body mass index increased in parallel with age. In women of the narcoleptic borderland (N = 260), the Epworth Sleepiness Scale markedly peaked in their early 30s, while body mass index only started to rise at that age. This rise in body mass index following the Epworth Sleepiness Scale peak cannot be explained by sleepiness‐induced uncontrolled eating, as self‐reported uncontrolled eating was negatively associated with the Epworth Sleepiness Scale in this group. We propose that the narcoleptic borderland harbours a unique cluster of women in their fertile years with an unexplored aetiology requiring further investigation towards tailored interventions.
- 21 October 2024
- Published by Wiley in Journal of Sleep Research
- Vol. 34 (3) , e14365
Open AccessDaytime sleepiness and BMI exhibit gender and age differences in patients with central disorders of hypersomnolence
Summary: The aim of the present study was to examine gender and age‐specific effects on subjective daytime sleepiness (as measured by the Epworth Sleepiness Scale), body weight and eating behaviour in patients with central disorders of hypersomnolence. Based on the European Narcolepsy Network database, we compared 1035 patients with narcolepsy type I and 505 patients with other central disorders of hypersomnolence (“narcoleptic borderland”), including narcolepsy type II (N = 308) and idiopathic hypersomnia (N = 174), using logistic regression and general linear models. In the entire study population, the Epworth Sleepiness Scale was higher in women (N = 735, mean age = 30 years, mean Epworth Sleepiness Scale = 16.6 ± SD 3.9) than in men (N = 805, mean age = 32 years, mean Epworth Sleepiness Scale = 15.8 ± SD 4.4). In women with narcolepsy type I (N = 475), both Epworth Sleepiness Scale and body mass index increased in parallel with age. In women of the narcoleptic borderland (N = 260), the Epworth Sleepiness Scale markedly peaked in their early 30s, while body mass index only started to rise at that age. This rise in body mass index following the Epworth Sleepiness Scale peak cannot be explained by sleepiness‐induced uncontrolled eating, as self‐reported uncontrolled eating was negatively associated with the Epworth Sleepiness Scale in this group. We propose that the narcoleptic borderland harbours a unique cluster of women in their fertile years with an unexplored aetiology requiring further investigation towards tailored interventions.
- Open Access
- 29 February 2024
- Published by Elsevier in Sleep Medicine
- Vol. 116, 105-114
Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations
- 29 February 2024
- Published by Elsevier in Sleep Medicine
- Vol. 116, 105-114
Open AccessPotential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations
- Open Access
- 23 January 2024
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 47 (6)
White matter integrity in narcolepsy: the structural blueprint for functional complaints?
Jari K Gool, Thien Thanh Dang-Vu, Ysbrand D van der Werf; White matter integrity in narcolepsy: the structural blueprint for functional complaints?, Sleep, , zs
- 23 January 2024
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 47 (6)
Open AccessWhite matter integrity in narcolepsy: the structural blueprint for functional complaints?
Jari K Gool, Thien Thanh Dang-Vu, Ysbrand D van der Werf; White matter integrity in narcolepsy: the structural blueprint for functional complaints?, Sleep, , zs
- Open Access
- 26 June 2023
- Published by Elsevier in Sleep Medicine
- Vol. 109, 118-127
The therapeutic potential of opioids in narcolepsy type 1: A systematic literature review and questionnaire study
- 26 June 2023
- Published by Elsevier in Sleep Medicine
- Vol. 109, 118-127
Open AccessThe therapeutic potential of opioids in narcolepsy type 1: A systematic literature review and questionnaire study
- Open Access
- 11 January 2023
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 46 (3)
What triggered narcolepsy: H1N1 vaccination, virus, or both? Important lessons learned from China
J Gool, M S Schinkelshoek, R Fronczek; What triggered narcolepsy: H1N1 vaccination, virus or both? Important lessons learned from China, Sleep, , zsad005, https
- 11 January 2023
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 46 (3)
Open AccessWhat triggered narcolepsy: H1N1 vaccination, virus, or both? Important lessons learned from China
J Gool, M S Schinkelshoek, R Fronczek; What triggered narcolepsy: H1N1 vaccination, virus or both? Important lessons learned from China, Sleep, , zsad005, https